Clinical Trials Directory

Trials / Completed

CompletedNCT05211973

Geriatric Anorexia Study 2.0

Developing Novel Digital Endpoints in Anorexia of Aging in Elderly Populations Residing in Long Term Care (LTC), Nursing Home, or Assisted Living Facilities

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Reduction in appetite and/or food intake among older individuals is referred to as anorexia of aging (AOA, also known as Geriatric Anorexia). AOA is linked with myriad comorbidities associated with aging, contributes significantly to adverse health consequences in old age, and has been used as a predictor of morbidity and mortality. The overall aim of this study is to compare feasibility of body weight, body fat, body composition and activity assessments in elderly subjects in long-term care (LTC), nursing home, or assisted living facilities. This will be accomplished through the use of questionnaires in addition to devices that evaluate movement, body composition, and body weight.

Detailed description

The overall aim of this study is to compare feasibility of body weight, body fat, body composition and activity assessments in elderly subjects in long-term care (LTC), nursing home, or assisted living facilities. This will be accomplished through the use of questionnaires in addition to devices that evaluate movement, body composition, and body weight. The proposed study will consist of an initial intake visit on Day 1, followed by an at-home (i.e. LTC facility, nursing home, and/or assisted living facility) phase where the participant will wear two watch like devices one on each wrist and answer two questions on paper each day. There will be a second visit on day 8 where the participant will complete additional questionnaires and assessments. The participant will continue wearing the wrist-worn devices for days 9-14, with a final visit on day 15 for final assessments and device collection. A window of +/- 3 days will be allocated for the scheduling of all visits to accommodate participant's schedules and commitments. Activities will take place in the care facility where the participant resides, or the Laboratory for Human Neurobiology for those that will commute. The study procedures will be identical for all participants for all Frailty groups.

Conditions

Interventions

TypeNameDescription
DEVICEWrist Actigraphy Devicea watch like wearable sensor
DEVICESmart Body Weight Scalea full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends (conducted based on participant's abilities)
DEVICEChair Scalea wheel-chair compatible scale to measure body weight
DEVICEHandheld Body Fat Percentage Devicea handheld device that measures body fat percentage
DEVICEBioelectric Impedance Analysis Scalea research-grade full body composition scale that provides fat and muscle mass, water retention, bone mass, and weight trends (conducted based on participant's abilities)

Timeline

Start date
2022-03-28
Primary completion
2022-09-07
Completion
2022-09-07
First posted
2022-01-27
Last updated
2022-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05211973. Inclusion in this directory is not an endorsement.